84.4% and Counting Earnings week opens with MRD receipts in hand.

Earnings week preview: Danaher tomorrow, then TMO & Roche Wednesday. Plus: 10x Genomics announces CLIA lab plans -spatial biology coming to the clinic. #MolDx #Diagnostics 👇
substack.com/@thedxwire/n...

CDx Market Heats Up Oncology CDx market projected to $12.84B by 2035 • Danaher, Thermo Fisher, Roche all report this week • FDA comment period closes in 6 days

Oncology CDx market projected to hit $12.84B by 2035 as FDA reclassification proposal gains momentum. Earnings week ahead: Danaher, Thermo Fisher, Roche all report. #MolDx #Diagnostics

open.substack.com/pub/thedxwir...

CDx Market Heats Up Oncology CDx market projected to $12.84B by 2035 • Danaher, Thermo Fisher, Roche all report this week • FDA comment period closes in 6 days

Oncology CDx market projected to hit $12.84B by 2035 as FDA reclassification proposal gains momentum. Earnings week
ahead: Danaher, Thermo Fisher, Roche all report. #MolDx #Diagnostics

open.substack.com/pub/thedxwir...

Natera-NVIDIA Partnership Signals AI-First Future for Precision Dx NeoGenomics RaDaR ST ready for market • Guardant Shield driving 335% volume growth • Thermo Fisher at 52-week hig

Natera taps NVIDIA to train AI foundation models at "unprecedented scale" - 75% faster genomic analysis, 45% faster
model training. The AI-diagnostics convergence is accelerating. #MolDx #PrecisionMedicine👇
open.substack.com/pub/thedxwir...

Check this out: Direct molecular testing shows promise in diagnosing invasive fungal disease from BAL specimens, offering faster results and greater sensitivity than traditional fungal culture. #ASMClinMicro #MolDx buff.ly/8rdl42k

False-negative CMV PCR results due to viral sequence variation: a diagnostic pitfall with the potential for serious consequences | ASM Case Reports Cytomegalovirus (CMV), a beta-herpes virus, causes significant morbidity and mortality in immunocompromised patients and is the leading cause of congenital infection and hearing loss in children in…

A genetic mutation in the PCR probe binding site delays CMV viremia detection, challenging standard diagnostics. This underscores the need for innovative approaches in disease management. #ASMCaseReports #MolDx buff.ly/jMGeA1N

Consider @JMDiagn for your next manuscript in #moldx and #molpath. We consider papers looking to improve diagnosis of #genetic conditions, #infectiousdisease, #hemathopathology disorders, #solidtumor, and healthcare #informatics.

Submission is free: https://loom.ly/LylFFhM

Include a Graphical Abstract with your next #moldx or #molpath submission to @JMDiagn!

Need help generating an eye catching and concise image for your work? Use the @Elsevier resources here to help: www.elsevier.com/researcher/author/tools-...

Consider @jmdiagn.bsky.social for submission of your next paper presenting novel developments in #moldx.

Submission is free!
https://www.editorialmanager.com/jmdi/default2.aspx

MolDX Gathers Experts to Review Medicare Coverage for EsoGuard® Esophageal DNA Test MolDX is set to hold a vital meeting with medical experts on September 4, 2025, to reassess Medicare coverage for Lucid Diagnostics' EsoGuard®, focusing on its implications for early esophageal cancer detection.

MolDX Gathers Experts to Review Medicare Coverage for EsoGuard® Esophageal DNA Test #United_States #New_York #Lucid_Diagnostics #EsoGuard #MolDX

Overcoming the Hurdles of Lab Reimbursement: From MolDx to Medical Necessity Reimbursement remains one of the most persistent and complex challenges facing clinical laboratories today. From medical documentation requests and denied claims to patient billing challenges, structu...

For years, labs performing most types of PCR testing in #MolDx jurisdictions have struggled to gain reimbursement due to the lack of approved clinical utility studies and subsequent lack of Z-Codes. www.bigmarker.com/lighthouse-l...

Consider @jmdiagn.bsky.social for publication of your next #molpath #moldx advancements. JMD is the official journal of
@ampath.bsky.social. #SolidTumor #InfectiousDisease #Informatics #Hematopathology #Genetics

Submission is free!

www.editorialmanager.com/jmdi/default...